Current insights into bacterial secondary infection following influenza A virus infection

Influenza A virus (IAV) continues to pose a substantial challenge to global health, not merely through primary viral pneumonia but largely due to lethal secondary bacterial complications. Pathogens such as Streptococcus pneumoniae , Staphylococcus aureus , and Haemophilus influenzae capitalize on the physiological “storm” induced by IAV, leading to significantly exacerbated morbidity. This review provides a comprehensive synthesis of the multifaceted mechanisms that dismantle host antibacterial defenses. Beyond the classical understanding of respiratory epithelial damage and the compensatory upregulation of bacterial adhesion receptors, we delve into the sophisticated dysregulation of innate immune signaling, specifically the collateral damage caused by interferon responses and impaired phagocytic function. Furthermore, we examine the complex roles of direct virus–bacterium synergism and the disruption of the respiratory microbiome (dysbiosis). By integrating these established paradigms, we extend the discussion to the rising clinical concern of nosocomial and multidrug-resistant (MDR) infections in critically ill patients. We conclude by identifying critical knowledge gaps and emphasizing the need for targeted strategies to mitigate the host vulnerabilities that permit opportunistic MDR colonization in the wake of viral insult.